Literature DB >> 8406789

Antibody-mediated enhancement of Legionella pneumophila-induced interleukin 1 activity.

R H Widen1, C A Newton, T W Klein, H Friedman.   

Abstract

The ability of antibody specific for Legionella pneumophila to enhance the induction of interleukin 1 (IL-1) production by murine peritoneal, splenic, and pulmonary macrophages in response to the bacterium was examined. Two preparations of L. pneumophila were utilized, a formalin-killed whole-cell preparation and viable bacteria. We measured both secreted (sIL-1) and cell membrane-associated (mIL-1) activities after incubation of the macrophages with the bacterial preparations in the presence or absence of the antibody. Both bacterial preparations induced sIL-1 and mIL-1 activities in each of the macrophage populations tested. These activities were generally enhanced by pretreating the bacteria with antibody, with the greatest enhancing activity observed for the formalin-killed preparations at lower doses of bacteria.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406789      PMCID: PMC281119          DOI: 10.1128/iai.61.10.4027-4032.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Role of interleukin-1 in infectious diseases.

Authors:  C A Dinarello
Journal:  Immunol Rev       Date:  1992-06       Impact factor: 12.988

2.  Acylation of cell-associated IL-1 by palmitic acid.

Authors:  O Bakouche; J L Moreau; L B Lachman
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

3.  Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.

Authors:  S B Mizel; J J Oppenheim; D L Rosentreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

4.  Purification and properties of human lymphocyte activating factor (LAF).

Authors:  G Blyden; R E Handschumacher
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

5.  Membrane IL-1: IL-1 alpha precursor binds to the plasma membrane via a lectin-like interaction.

Authors:  D T Brody; S K Durum
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

6.  Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.

Authors:  L Chen; Y Suzuki; E F Wheelock
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

7.  Isolation and cultivation in vitro of macrophages from various sources in the mouse.

Authors:  B Bennett
Journal:  Am J Pathol       Date:  1966-01       Impact factor: 4.307

8.  Detection of IL-1 alpha and IL-1 beta in the supernatants of paraformaldehyde-treated human monocytes. Evidence against a membrane form of IL-1.

Authors:  J Suttles; L M Carruth; S B Mizel
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

9.  Enhancement of polymorphonuclear cell phagocytosis by lipid A-activated monocytes via cell-to-cell contact. A possible role for membrane-associated cytokines.

Authors:  E Jirillo; P Decandia; M R Ribaud; B Cannuscio; C De Simone; S Antonaci
Journal:  Immunopharmacol Immunotoxicol       Date:  1992       Impact factor: 2.730

Review 10.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

View more
  3 in total

Review 1.  New concepts in antibody-mediated immunity.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

2.  Quantitative reverse transcription-PCR analysis of Legionella pneumophila-induced cytokine mRNA in different macrophage populations by high-performance liquid chromatography.

Authors:  Y Yamamoto; C Retzlaff; P He; T W Klein; H Friedman
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

3.  Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA.

Authors:  Y Yamamoto; S Okubo; T W Klein; K Onozaki; T Saito; H Friedman
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.